In recent years, the treatments of breast cancer focus on the identification of cytokines as prognostic factors, including several interleukins (IL-1, IL-6, IL-10), transforming growth factor-β (TGF-β), tumor necrosis factor-a (TNF-a) and so on [16]. Here, TNF is linked to breast carcinoma.